Cerus Corporation

(CERS) Trade

By |

Profile

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: blood safety and generates revenue from the same.

Contact Information

Website: www.cerus.com
Email: ir@cerus.com
Main Phone: +1 925 288-6000
Address: 2550 Stanwell Drive
State: CA
City / Town: Concord
Country: USA
Postal Code: 94520

Issuer Information

Exchange: NSD
CEO: William M. Greenman
Employees: 215
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 5.78 $ 0.23 (4.14%)
Last Price 5.78 Change $ 0.23 Change % 4.14 Tick N/A
Bid 5.78 Bid Size 200.00 Ask 5.79 Ask Size 1,000.00
Open 5.64 High 5.82 Low 5.63 Prev Close 5.55
Last Trade Volume 1 mi 52 Wk Hi 8.05 52 Wk Low 3.35
Market Cap 784.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 135,689,199.00 EPS (TTM) -0.42 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 25 54
Number of Buys 15 34
Number of Sells 10 20
Net Activity 77003 398307
Last 10 Buys Shares
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Laurence M. Corash 1,000
Last 10 Sell Shares
Gail Gaumer Schulze 1,000
Gail Gaumer Schulze 1,000
Carol M. Moore 1,000
Carol M. Moore 1,000
Timothy B. Anderson 1,000
Timothy B. Anderson 1,000
Kevin D. Green 1,000
Kevin D. Green 1,000
Carol M. Moore 1,000
Richard J. Benjamin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 7.5 7 7 7.5
Standard Deviation 1.29 1.41 1.41 1.29
Date of Most Recent Estimate 06/04/18 05/22/18 05/22/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.4